Effects of aromatic retinoid (Ro 109359) on Langerhans' cells in lichen planus
- 1 April 1983
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 275 (2) , 105-108
- https://doi.org/10.1007/bf00412884
Abstract
Retinoids are used in the treatment of lichen planus (LP) disease, but their mechanism of action remains unknown. We studied the epidermal Langerhans' cells in four patients with chronic LP, before and after treatment with aromatic retinoids. This study uses a new technique of quantification and exploits two monoclonal antibodies — OKT 6 specific for Langerhans' cells and BL 2 specific for HLA-DR antigens. Our results show an increase in the number of dendritic epidermal cells after treatment with oral retinoids. The number of OKT 6-positive cells is greater than the number of BL 2-positive (HLA-DR) cells before and after treatment.This publication has 20 references indexed in Scilit:
- A Method for Quantifying Langerhans Cells in Epidermal Sheets of Human and Murine SkinTissue Antigens, 2008
- Specificity of monoclonal antibody anti-T-6 for Langerhans' cells in normal human skinBritish Journal of Dermatology, 1982
- Effect of glucocorticosteroids on epidermal Langerhans cells.The Journal of Experimental Medicine, 1982
- Influence of Retinoid Ro 10-9359 on Cell-Mediated Immunity in vivoDermatology, 1982
- T cell subsets and Langerhans cells in lichen planus: in situ characterization using monoclonal antibodiesBritish Journal of Dermatology, 1981
- A New Immunologic Marker for Human Langerhans CellsNew England Journal of Medicine, 1981
- Natural and Perturbed Distributions of Langerhans Cells: Responses to Ultraviolet Light, Heterotopic Skin Grafting, and Dinitrofluorobenzene SensitizationJournal of Investigative Dermatology, 1980
- Tolerance or Hypersensitivity to 2,4-dinitro-1-fluorobenzene: The Role of Langerhans Cell Density within EpidermisJournal of Investigative Dermatology, 1980